Publications by authors named "P Urruzuno"
Article Synopsis
- The study aimed to evaluate the effectiveness of colloidal bismuth subcitrate (CBS) in eliminating H. pylori infections in children aged 5-18, using data from a national pediatric registry.
- Out of 682 patients in the registry, 38 were treated with CBS, and 93.8% of those treated successfully eradicated the infection, showing better results compared to non-CBS treatments.
- The findings indicate that CBS therapies can be highly effective even in patients with prior unsuccessful treatments, although they were used in a limited scope and at lower-than-ideal dosages.
Article Synopsis
- - The study analyzed treatment decisions for H. pylori infection in children using data from the EuroPedHp Registry, focusing on various factors influencing whether or not therapy was administered, especially regarding gastrointestinal (GI) comorbidities.
- - Out of 1165 pediatric patients, those with GI comorbidities were significantly less likely to receive eradication treatment (only 57%) compared to those with no comorbidities (89%) despite having similar symptoms and conditions.
- - The findings suggest that H. pylori-infected children with GI issues had a much lower chance (75% reduced) of receiving treatment, indicating no rationale for different management approaches based on GI comorbidities in pediatric patients with confirmed infections.
Background: Helicobacter pylori may be found during upper gastrointestinal endoscopy (UGE) performed to diagnose celiac disease (CeD), inflammatory bowel disease (IBD), and eosinophilic esophagitis (EoE). We aimed to describe the frequency of H. pylori in children undergoing UGE for CeD, IBD, and EoE and the number of children receiving eradication treatment.
View Article and Find Full Text PDFCeliac disease is strongly associated with HLA DQ, specifically with haplotypes. DRB1*03-DQA1*05:01/DQB1*02:01 (DQ2.5),DRB1*07-DQA1*02:01/DQB1*02:02 (DQ2.
View Article and Find Full Text PDFPurpose: The EuroPedHp-registry aims to monitor guideline-conform management, antibiotic resistance, and eradication success of 2-week triple therapy tailored to antibiotic susceptibility (TTT) in Helicobacter pylori-infected children.
Methods: From 2017 to 2020, 30 centres from 17 European countries reported anonymized demographic, clinical, antibiotic susceptibility, treatment, and follow-up data. Multivariable logistic regression identified factors associated with treatment failure.